The global in vitro fertilization market size was estimated to be USD 25.23 billion in 2023 and is expected to reach at USD 52.68 billion by 2034 with a CAGR of 6.92% during the forecast period 2024-2034. Rising incidences of male & female infertility, increasing re-tourism, surge in number of median age women & men getting married & have their first child, growing number of women seeking the In Vitro Fertilization (IVF) treatment, rising adoption of techniques such as Testicular Sperm Extraction (PESA and TESE), increasing focus on development of new products, surge in awareness regarding infertility, infertility treatment, & their services, growing advancements in IVF technology, rising number of delayed pregnancies, and increasing introduction of AI-based IVF technology platform are some of the key factors boosting the market growth.
Increasing approval of AI-based IVF technology platform is predicted to boost the market growth during the forecast period. Due to the high success rate of IVF procedures including assisted hatching, vitrification, egg/sperm freezing, and Percutaneous Epidydimal Sperm Aspiration & Testicular Sperm Extraction (PESA and TESE), market participants are concentrating on the development of new products. For instance, in July 2022, Fairtility has received approval from the European Union to utilize artificial intelligence for evaluating embryos. The EU's updated medical device regulations have paved the way for the creation of a commercially accessible AI solution, which has the capacity to enhance the success rate of in vitro fertilization (IVF) treatments.
By product, instrument was the highest revenue-grossing segment in the global in vitro fertilization market in 2023 owing to increasing focus on developing novel devices for use in assisted reproductive technology (ART) procedures conducted by fertility clinics & obstetrician-gynecologist (OB/GYN) practices, rising use of sperm syringes to select high-quality sperm, growing technological advancements in the sperm separation, and surge in research & development activities. For instance, in March 2022, In an international partnership with commercialization advisors from the University City Science Center, Malta has initiated the research and development of an AI-driven technology for selecting sperm and eggs in fertility treatments. Pera Labs, based in Malta, has received a boost in its operations with EUR 800,000 in financial backing from Malta Enterprise, in addition to funding from Pera Labs itself. Additionally, reagent is predicted to grow at fastest CAGR during the forecast period owing to the increasing funding for the development of innovative products, growing research & development activities, surge in introduction of disposable devices, and rising approvals by regulatory bodies.
By type, IVF with ICSI was the highest revenue-grossing segment in the global in vitro fertilization market in 2023 owing to the success rate of ICSI techniques for in vitro fertilization and its growing use during IVF operations. Additionally, conventional IVF is predicted to grow at fastest CAGR during the forecast period owing to the surge in awareness regarding infertility, increasing focus on development of advanced products, and rising launch of new products. For instance, in July 2022, FUJIFILM Irvine Scientific has introduced Heavy Oil for Embryo Culture, a sterile mineral oil designed for use in embryo culture during IVF procedures. This product effectively addresses key concerns such as pH balance, osmolality fluctuations, and media preservation, thanks to its optimal viscosity and weight.
By procedure type, fresh non-donor was the highest revenue-grossing segment in the global in vitro fertilization market in 2023 owing to increasing prevalence of infertility combined with high success rate of IVF procedures using fresh eggs or embryos and surge in part Partnership and collaborations within market players. For instance, in January 2022, Boston IVF, a renowned fertility service provider with extensive experience, has entered into a partnership with the Delaware Institute for Reproductive Medicine (DIRM). This distinctive collaboration seeks to bring top-tier fertility treatments and services to the local community, including cutting-edge procedures such as in vitro fertilization (IVF), preimplantation genetic testing, male infertility treatments, and more. Additionally, frozen non-donor is predicted to grow at fastest CAGR during the forecast period owing to its low cost than the IVF cycles using fresh eggs or embryos and increasing technological advancements in IVF platforms.
By end-user, fertility clinics was the highest revenue-grossing segment in the global in vitro fertilization market in 2023 owing to the cost-effectiveness, increasing availability of specialists, growing demand for ART treatments, surge in number of fertility clinics & ART centres, and rising initiatives by leading market players. For instance, in June 2022, Oma Fertility has recently revealed itself to the public and unveiled an unprecedented network of fertility clinics. These clinics are pioneering the use of science-driven, AI-informed approaches to fertility treatments, potentially setting a new benchmark for IVF success rates in the industry. Additionally, hospitals is predicted to grow at fastest CAGR during the forecast period owing to the surge in number of IVF treatments performed within hospitals, rising preference for hospitals for infertility treatments, and increasing adoption of advanced technologies by hospitals.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing prevalence of polycystic ovary syndrome (PCOS), surge in government funding for sperm & egg storage, rising prevalence of infertility in both sexes, growing demand for infertility treatment device by factors such as newly opened fertility centers & reimbursement policies for infertility treatment, and increasing collaborations within market players. For instance, in May 2023, AIVF Ltd., a company with expertise in AI-driven solutions for IVF clinics, has partnered with Genea Biomedx, a medical device provider specializing in IVF laboratories. Together, they have introduced an all-encompassing and economically efficient integrated system solution for individualized IVF care. This collaboration combines Genea Biomedx's Geri time-lapse incubator with AIVF Ltd.'s EMA AI platform, resulting in a robust suite that provides broad access to tailored and optimized IVF treatments. Additionally, Europe region is predicted to grow at fastest CAGR during the forecast period owing to surge in fertility tourism, rising investment by major market players, increasing cases of infertility, growing introduction of more & advanced IVF treatments, and surge in partnerships & collaborations within leading market players. For instance, in June 2023, Progyny, Inc. and Quantum Health, Inc. have teamed up to launch Quantum Health's Comprehensive Care Solutions platform, specifically designed for family building and fertility solutions.
Increasing approval of AI-based IVF technology platform is predicted to boost the market growth during the forecast period. Due to the high success rate of IVF procedures including assisted hatching, vitrification, egg/sperm freezing, and Percutaneous Epidydimal Sperm Aspiration & Testicular Sperm Extraction (PESA and TESE), market participants are concentrating on the development of new products. For instance, in July 2022, Fairtility has received approval from the European Union to utilize artificial intelligence for evaluating embryos. The EU's updated medical device regulations have paved the way for the creation of a commercially accessible AI solution, which has the capacity to enhance the success rate of in vitro fertilization (IVF) treatments.
By product, instrument was the highest revenue-grossing segment in the global in vitro fertilization market in 2023 owing to increasing focus on developing novel devices for use in assisted reproductive technology (ART) procedures conducted by fertility clinics & obstetrician-gynecologist (OB/GYN) practices, rising use of sperm syringes to select high-quality sperm, growing technological advancements in the sperm separation, and surge in research & development activities. For instance, in March 2022, In an international partnership with commercialization advisors from the University City Science Center, Malta has initiated the research and development of an AI-driven technology for selecting sperm and eggs in fertility treatments. Pera Labs, based in Malta, has received a boost in its operations with EUR 800,000 in financial backing from Malta Enterprise, in addition to funding from Pera Labs itself. Additionally, reagent is predicted to grow at fastest CAGR during the forecast period owing to the increasing funding for the development of innovative products, growing research & development activities, surge in introduction of disposable devices, and rising approvals by regulatory bodies.
By type, IVF with ICSI was the highest revenue-grossing segment in the global in vitro fertilization market in 2023 owing to the success rate of ICSI techniques for in vitro fertilization and its growing use during IVF operations. Additionally, conventional IVF is predicted to grow at fastest CAGR during the forecast period owing to the surge in awareness regarding infertility, increasing focus on development of advanced products, and rising launch of new products. For instance, in July 2022, FUJIFILM Irvine Scientific has introduced Heavy Oil for Embryo Culture, a sterile mineral oil designed for use in embryo culture during IVF procedures. This product effectively addresses key concerns such as pH balance, osmolality fluctuations, and media preservation, thanks to its optimal viscosity and weight.
By procedure type, fresh non-donor was the highest revenue-grossing segment in the global in vitro fertilization market in 2023 owing to increasing prevalence of infertility combined with high success rate of IVF procedures using fresh eggs or embryos and surge in part Partnership and collaborations within market players. For instance, in January 2022, Boston IVF, a renowned fertility service provider with extensive experience, has entered into a partnership with the Delaware Institute for Reproductive Medicine (DIRM). This distinctive collaboration seeks to bring top-tier fertility treatments and services to the local community, including cutting-edge procedures such as in vitro fertilization (IVF), preimplantation genetic testing, male infertility treatments, and more. Additionally, frozen non-donor is predicted to grow at fastest CAGR during the forecast period owing to its low cost than the IVF cycles using fresh eggs or embryos and increasing technological advancements in IVF platforms.
By end-user, fertility clinics was the highest revenue-grossing segment in the global in vitro fertilization market in 2023 owing to the cost-effectiveness, increasing availability of specialists, growing demand for ART treatments, surge in number of fertility clinics & ART centres, and rising initiatives by leading market players. For instance, in June 2022, Oma Fertility has recently revealed itself to the public and unveiled an unprecedented network of fertility clinics. These clinics are pioneering the use of science-driven, AI-informed approaches to fertility treatments, potentially setting a new benchmark for IVF success rates in the industry. Additionally, hospitals is predicted to grow at fastest CAGR during the forecast period owing to the surge in number of IVF treatments performed within hospitals, rising preference for hospitals for infertility treatments, and increasing adoption of advanced technologies by hospitals.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing prevalence of polycystic ovary syndrome (PCOS), surge in government funding for sperm & egg storage, rising prevalence of infertility in both sexes, growing demand for infertility treatment device by factors such as newly opened fertility centers & reimbursement policies for infertility treatment, and increasing collaborations within market players. For instance, in May 2023, AIVF Ltd., a company with expertise in AI-driven solutions for IVF clinics, has partnered with Genea Biomedx, a medical device provider specializing in IVF laboratories. Together, they have introduced an all-encompassing and economically efficient integrated system solution for individualized IVF care. This collaboration combines Genea Biomedx's Geri time-lapse incubator with AIVF Ltd.'s EMA AI platform, resulting in a robust suite that provides broad access to tailored and optimized IVF treatments. Additionally, Europe region is predicted to grow at fastest CAGR during the forecast period owing to surge in fertility tourism, rising investment by major market players, increasing cases of infertility, growing introduction of more & advanced IVF treatments, and surge in partnerships & collaborations within leading market players. For instance, in June 2023, Progyny, Inc. and Quantum Health, Inc. have teamed up to launch Quantum Health's Comprehensive Care Solutions platform, specifically designed for family building and fertility solutions.
Segmentation: In Vitro Fertilization Market Report 2022 - 2033
In Vitro Fertilization Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Reagent
- Instrument
- Ovum Aspiration Pump
- Imaging Systems
- Incubators
- IVF Cabinet
- Cryosystems
- Micromanipulator Systems
- Sperm Separation Systems
- Others
In Vitro Fertilization Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)
- IVF With Donor Eggs
- Conventional IVF
- IVF With ICSI
- Others
In Vitro Fertilization Market Analysis & Forecast by Procedure Type 2023 - 2034 (Revenue USD Bn)
- Fresh Non-Donor
- Fresh Donor
- Frozen Non-Donor
- Frozen Donor
In Vitro Fertilization Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Hospitals
- Fertility Clinics
- Others
In Vitro Fertilization Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. In Vitro Fertilization Market: Product Estimates & Trend Analysis
8. In Vitro Fertilization Market: Type Estimates & Trend Analysis
9. In Vitro Fertilization Market: Procedure Type Estimates & Trend Analysis
10. In Vitro Fertilization Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America In Vitro Fertilization Market
13. Europe Global In Vitro Fertilization Market
14. Asia Pacific Global In Vitro Fertilization Market
15. Latin America Global In Vitro Fertilization Market
16. MEA Global In Vitro Fertilization Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- New Hope Fertility Centre
- Reproductive Medicine Associates
- Fertility And Gynecology Centre Monterey Bay IVF
- Servy Massey Fertility Institute
- Boston IVF
- Cardone Reproductive Medicine And Infertility LLC
- Conceptions Reproductive Associates Of Colorado
- Houston Fertility Centre
- Fertility Centre Of San Antoni
- Sher Institute For Reproductive Medicine (Sirm)
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | October 2023 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 25.23 Billion |
| Forecasted Market Value ( USD | $ 52.68 Billion |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
